Ovintiv Investing Cash Flow decreased by 77.7% to -$1.74B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 94.2%, from -$895.00M to -$1.74B. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 53.1% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $568.00M | -$367.00M | -$405.00M | -$417.00M | -$514.00M | -$264.00M | -$591.00M | -$863.00M | -$3.01B | -$854.00M | -$794.00M | -$761.00M | -$641.00M | -$516.00M | -$539.00M | -$895.00M | -$558.00M | -$453.00M | -$978.00M | -$1.74B |
| QoQ Change | — | -164.6% | -10.4% | -3.0% | -23.3% | +48.6% | -123.9% | -46.0% | -248.6% | +71.6% | +7.0% | +4.2% | +15.8% | +19.5% | -4.5% | -66.0% | +37.7% | +18.8% | -115.9% | -77.7% |
| YoY Change | — | — | — | — | -190.5% | +28.1% | -45.9% | -107.0% | -485.2% | -223.5% | -34.3% | +11.8% | +78.7% | +39.6% | +32.1% | -17.6% | +12.9% | +12.2% | -81.4% | -94.2% |